An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer
An Open-Label, Multicentre, Randomised, Phase III Study Comparing Oral Topotecan to Intravenous Docetaxel in Patients With Pretreated Advanced Non Small Cell Lung Cancer
The purpose of this study is to collect information on how effective and how well tolerated an oral investigational drug is compared to a standard intravenous drug in patients with pretreated, advanced non-small lung cancer (NSCLC).
Inclusion Criteria:
Exclusion Criteria:
Braasschaat, 2930, Belgium
Wangfujing, Beijing, 100730, China
Toulon Naval, 83800, France
Papagos, Athens, 15669, Greece
Rio, Patras, 265 00, Greece
Newtown, Wellington, 6002, New Zealand
Tau-Yuan County, 333, Taiwan